Recent Advances in the Clinical Diagnosis and Management of Frontotemporal Lobar Degeneration and Dementia with Lewy Bodies

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".

Deadline for manuscript submissions: 25 March 2024 | Viewed by 2231

Special Issue Editor

Medway School of Pharmacy, University of Kent, Anson Building, Canterbury ME4 4TB, UK
Interests: alzheimer’s disease; traumatic brain injury; neuropathology; COVID-19
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The early diagnosis of frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB) remains challenging as their clinical and pathological features overlap with Alzheimer’s disease and other types of dementia. The identification of clinical biomarkers is essential to improve the accuracy of diagnosis and the development of disease-modifying therapies.

This Special Issue of the Journal of Clinical Medicine aims to gather cutting-edge research to enhance our understanding of FTLD and DLB and pave the way to novel diagnostic and therapeutic strategies.

The following aspects of FTLD and DLB will be covered:

  • Clinical presentation;
  • Diagnosis;
  • Neuropathology;
  • Neuroimaging;
  • Biomarkers;
  • Management;
  • Disease-modifying therapies.

We look forward to receiving your original research and review articles.

Dr. Romina Vuono
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • dementia
  • FTLD
  • DLB
  • biomarkers
  • neuroimaging
  • differential diagnosis
  • therapy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

14 pages, 1007 KiB  
Case Report
Combining Neuropsychological Assessment with Neuroimaging to Distinguish Early-Stage Alzheimer’s Disease from Frontotemporal Lobar Degeneration in Non-Western Tonal Native Language-Speaking Individuals Living in Taiwan: A Case Series
J. Clin. Med. 2023, 12(4), 1322; https://doi.org/10.3390/jcm12041322 - 07 Feb 2023
Viewed by 1805
Abstract
Neuropsychological tests (NPTs), which are routinely used in clinical practice for assessment of dementia, are also considered to be essential for differential diagnosis of Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD), especially the behavioral variants of frontotemporal dementia (bvFTD) and primary progressive [...] Read more.
Neuropsychological tests (NPTs), which are routinely used in clinical practice for assessment of dementia, are also considered to be essential for differential diagnosis of Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD), especially the behavioral variants of frontotemporal dementia (bvFTD) and primary progressive aphasia (PPA) at their initial clinical presentations. However, the heterogeneous features of these diseases, which have many overlapping signs, make differentiation between AD and FTLD highly challenging. Moreover, NPTs were primarily developed in Western countries and for native speakers of non-tonal languages. Hence, there is an ongoing dispute over the validity and reliability of these tests in culturally different and typologically diverse language populations. The purpose of this case series was to examine which of the NPTs adjusted for Taiwanese society may be used to distinguish these two diseases. Since AD and FTLD have different effects on individuals’ brain, we combined NPTs with neuroimaging. We found that participants diagnosed with FTLD had lower scores in NPTs assessing language or social cognition than AD participants. PPA participants also had lower measures in the Free and Cued Selective Reminding Test than those diagnosed with bvFTD, while bvFTD participants showed poorer performances in the behavioral measures than PPA participants. In addition, the initial diagnosis was supported by the standard one-year clinical follow-up. Full article
Show Figures

Figure 1

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

  • dementia
  • FTLD
  • DLB
  • biomarkers
  • neuroimaging
  • differential diagnosis
  • therapy
Back to TopTop